NEW! Investment Companies Centre

Alizyme (AZM)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE Small Cap

Market Cap

£21.84m

Change Today

Price Down-0.62p ()

Share Price

9.88p

Notification of shares

RNS Number : 4003E
Alizyme PLC
26 September 2008
 



For Immediate Release

26 September 2008


ALIZYME PLC


TR - 1:

NOTIFICATION OF MAJOR INTERESTS IN SHARES



  • Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:


Alizyme plc


2.    Reason for the notification:


An acquisition or disposal of voting rights



3.    Full name of person(s) subject to the notification obligation:


UBS Investment Bank


4.    Full name of shareholder(s) (if different from 3.):


UBS AG


5.    Date of the transaction and date on which the threshold is crossed or reached:


    23 September 2008


6.    Date on which issuer notified:


    25 September 2008


7.    Threshold(s) that is/are crossed or reached:


    8 % 


8.    Notified details:


A: Voting rights attached to shares


Class/type of shares

if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights


Direct

Indirect

Direct

Indirect

Ordinary Shares

GB0000374289

19,124,314

19,124,314

17,414,701

17,414,701

-

7.88%

-

  

B: Financial Instruments


Resulting situation after the triggering transaction

Type of financial instrument 

Expiration date

Exercise/ Conversion

Period/Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights


n/a


n/a


n/a


n/a


n/a


Total (A+B)


Number of voting rights

% of voting rights

17,414,701

7.88%



9.             Chain of controlled undertakings through which the voting rights and/or the financial  
          instruments are effectively held, if applicable:


n/a


Proxy Voting:


10.    Name of the proxy holder:


n/a


11.     Number of voting rights proxy holder will cease to hold:


n/a


12.     Date on which proxy holder will cease to hold voting rights:


n/a


13.    Additional information:


n/a


14.    Contact name:


    Nick Blech, Company Secretary


15.    Contact telephone number:


    +44 (0) 1223 896000


Further information on Alizyme can be found on the Company's website: www.alizyme.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSESSUMSASEFU

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).